Section Arrow
Quote
PMN.NASDAQ
- Promis Neurosciences Inc.
Quotes are at least 15-min delayed:2026/01/02 12:01 EST
Regular Hours
Last
 7.2
+0.375 (+5.49%)
Day High 
7.22 
Prev. Close
6.825 
1-M High
9.42 
Volume 
5.39K 
Bid
7.05
Ask
7.22
Day Low
6.72 
Open
6.72 
1-M Low
6.62 
Market Cap 
14.53M 
Currency 美元 
P/E 6.98 
%Yield -- 
10-SMA 7.93 
20-SMA 8.17 
50-SMA 9.05 
52-W High 39.75 
52-W Low 6.27 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-20.00/-7.99
Enterprise Value
18.41M
Balance Sheet
Book Value Per Share
4.27
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
253.70K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OTLKOutlook Therapeutics0.68345-0.89655-56.74%0.58PE
MREOMereo BioPharma Group plc0.474+0.0573+13.75%-- 
SLSSELLAS Life Sciences Group4.145+0.375+9.95%-- 
ASBPAspire Biopharma Holdings Inc.0.1411+0.0092+6.97%-- 
RXRXRecursion Pharmaceuticals4.175+0.085+2.08%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes onthe molecular surface of misfolded proteins.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.